TSH Biopharm Corporation Limited (TPEX:8432)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
50.90
-0.30 (-0.59%)
At close: Mar 26, 2026

TSH Biopharm Corporation Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,9542,2462,3541,9311,8261,709
Market Cap Growth
-11.63%-4.57%21.87%5.78%6.85%-24.45%
Enterprise Value
1,3161,6101,7851,2301,111926
Last Close Price
50.9058.5058.7447.2343.0938.91
PE Ratio
14.0616.1320.8131.1629.5036.27
PS Ratio
1.461.682.112.382.464.13
PB Ratio
1.141.311.451.531.511.58
P/TBV Ratio
1.691.952.131.831.771.58
P/FCF Ratio
14.4816.6412.9367.7959.6225.01
P/OCF Ratio
14.0116.1012.8157.0253.1524.87
EV/Sales Ratio
0.981.211.601.521.502.24
EV/EBITDA Ratio
5.406.969.6415.8414.0215.21
EV/EBIT Ratio
6.037.3710.5119.3316.8316.65
EV/FCF Ratio
9.7511.939.8143.1836.2813.55
Debt / Equity Ratio
0.010.010.010.010.050.00
Debt / EBITDA Ratio
0.080.080.100.090.730.07
Debt / FCF Ratio
0.140.140.110.262.060.07
Net Debt / Equity Ratio
-0.53-0.53-0.54-0.60-0.62-0.67
Net Debt / EBITDA Ratio
-3.95-3.95-4.74-9.85-9.49-11.97
Net Debt / FCF Ratio
-6.77-6.77-4.82-26.84-24.58-10.67
Asset Turnover
0.710.710.690.570.570.35
Inventory Turnover
3.953.953.623.643.892.20
Quick Ratio
5.495.495.327.354.969.72
Current Ratio
6.276.276.258.345.5610.72
Return on Equity (ROE)
11.24%11.24%9.29%5.24%5.76%4.26%
Return on Assets (ROA)
7.20%7.20%6.55%2.81%3.17%2.90%
Return on Invested Capital (ROIC)
21.70%22.54%21.06%11.30%13.19%11.14%
Return on Capital Employed (ROCE)
12.70%12.70%10.40%5.00%5.40%5.10%
Earnings Yield
7.13%6.20%4.81%3.21%3.39%2.76%
FCF Yield
6.91%6.01%7.73%1.47%1.68%4.00%
Dividend Yield
5.10%4.46%3.61%2.71%3.71%3.85%
Payout Ratio
58.45%58.45%43.46%99.11%93.06%146.72%
Buyback Yield / Dilution
-0.05%-0.05%-0.04%0.05%-0.05%-0.01%
Total Shareholder Return
5.05%4.42%3.57%2.76%3.66%3.85%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.